Home-based Fecal Calprotectin Testing: A Canadian User Performance Evaluation Study of IBDoc®

BÜHLMANN IBDoc®:

Wong, A, Bourdages, R. et al. Home-based Fecal Calprotectin Testing: A Canadian User Performance Evaluation Study of IBDoc®.  CDDW 2018, Feb 09 – 11, 2018. Toronto, ON Canada.

Highlights from this Publication

“Conclusions. The IBDoc® test kit was understood by participants, with a majority of participants finding it easy to use, with an understandable display and a product that they are likely to use in the future…FC measurements obtained by participants using the IBDoc® were strongly correlated with the standard FC ELISA measurements..”

Read Citation

Health Canada Licence: 98903, Device class: 3 

BÜHLMANN IBDoc® is Not Available for Sale in the US.